Several TRP channels have been studied as potential biological markers of glioma progression and prognosis, including TRPC1, TRPC6, TRPM2, TRPM3, TRPM7, TRPM8, TRPV1/2. This evidence concerns the gene TRPM3 and central nervous system cancer.